Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **kinase allosteric site** refers to non-ATP (non-orthosteric) binding regions within protein kinases that can be modulated by small molecules, peptides, or regulatory proteins. These sites are structurally distinct from the active (catalytic) center but communicate with it through conformational changes, enabling selective inhibition or activation of kinase activity. Targeting allosteric sites provides opportunities for greater specificity and the ability to overcome resistance mechanisms associated with traditional ATP-competitive inhibitors. Allosteric regulation is a key facet of kinase biology, underlying their role as cellular switches in signal transduction, cell cycle control, and various disease states
Allosteric modulation (activation or inhibition) of kinase enzymatic activity by binding to a site distinct from the ATP (orthosteric) site, potentially altering kinase conformation, dynamics, or regulatory elements
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinase allosteric site.